Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application

References

• Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 1999;40(Suppl 1):S3-8
   PubMed Web of Science ®Google Scholar
• Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001;42(6):714-18
   PubMed Web of Science ®Google Scholar
• DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46(4):1029-35
   PubMed Web of Science ®Google Scholar
• Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014;20(3):476-83
   PubMed Web of Science ®Google Scholar
• Holtkamp M. The anaesthetic and intensive care of status epilepticus. Curr Opin Neurol 2007;20(2):188-93
   PubMed Web of Science ®Google Scholar
• Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59(2):205-10
   PubMed Web of Science ®Google Scholar
• Kellinghaus C, Stogbauer F. Treatment of status epilepticus in a large community hospital. Epilepsy Behav 2012;23(3):235-40
   PubMed Web of Science ®Google Scholar
• Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia 2010;51(2):251-6
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Milligan TA, Vulliemoz S, et al. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011;14(1):4-10
   PubMed Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134(Pt 10):2802-18
   PubMed Web of Science ®Google Scholar
• Trinka E, Cock H, Hesdorffer DC, et al. A definition and classification of status epilepticus-Report of the task force on classification of status epilepticus. Epilepsia 2015. [Epub ahead of print]
   Google Scholar
• Shorvon S. The classification of status epilepticus. Epileptic Disord 2005;7(1):1-3
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006;77(5):611-15
   PubMed Web of Science ®Google Scholar
• Alvarez V, Westover MB, Drislane FW, et al. Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia 2014;55(12):2059-68
   PubMed Web of Science ®Google Scholar
• Spatola M, Novy J, Du Pasquier R, et al. Status epilepticus of inflammatory etiology: a cohort study. Neurology 2015;85(5):464-70
   PubMedGoogle Scholar
• Amare A, Zenebe G, Hammack J, Davey G. Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients. Epilepsia 2008;49(4):600-7
   PubMed Web of Science ®Google Scholar
• Holzer FJ, Seeck M, Korff CM. Autoimmunity and inflammation in status epilepticus: from concepts to therapies. Expert Rev Neurother 2014;14(10):1181-202
   PubMed Web of Science ®Google Scholar
• Holzer FJ, Rossetti AO, Heritier-Barras AC, et al. Antibody-mediated status epilepticus: a retrospective multicenter survey. Eur Neurol 2012;68(5):310-17
   PubMed Web of Science ®Google Scholar
• Holtkamp M, Othman J, Buchheim K, et al. A “malignant” variant of status epilepticus. Arch Neurol 2005;62(9):1428-31
   PubMed Web of Science ®Google Scholar
• Wilder-Smith EP, Lim EC, Teoh HL, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore 2005;34(7):417-20
   PubMed Web of Science ®Google Scholar
• Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011;10(1):99-108
   PubMed Web of Science ®Google Scholar
• van Baalen A, Hausler M, Boor R, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010;51(7):1323-8
   PubMed Web of Science ®Google Scholar
• Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE) - The potential role for immunotherapy. Epilepsy Behav 2015;47:17-23
   PubMed Web of Science ®Google Scholar
• Logroscino G, Hesdorffer DC, Cascino GD, et al. Long-term mortality after a first episode of status epilepticus. Neurology 2002;58(4):537-41
   PubMed Web of Science ®Google Scholar
• Sutter R, Kaplan PW, Ruegg S. Outcome predictors for status epilepticus–what really counts. Nat Rev Neurol 2013;9(9):525-34
   PubMed Web of Science ®Google Scholar
• Hocker SE, Britton JW, Mandrekar JN, et al. Predictors of outcome in refractory status epilepticus. JAMA Neurol 2013;70(1):72-7
   PubMed Web of Science ®Google Scholar
• Aminoff MJ. Do nonconvulsive seizures damage the brain?–No. Arch Neurol 1998;55(1):119-20
   PubMed Web of Science ®Google Scholar
• Young GB, Jordan KG. Do nonconvulsive seizures damage the brain?–Yes. Arch Neurol 1998;55(1):117-19
   PubMed Web of Science ®Google Scholar
• Fernandez-Torre JL, Figols J, Martinez-Martinez M, et al. Localisation-related nonconvulsive status epilepticus: Further evidence of permanent cerebral damage. J Neurol 2006;253(3):392-5
   PubMed Web of Science ®Google Scholar
• Salmenpera T, Kalviainen R, Partanen K, et al. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus. Epilepsy Res 2000;40(2-3):155-70
   PubMed Web of Science ®Google Scholar
• Adachi N, Kanemoto K, Muramatsu R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia 2005;46(9):1502-9
   PubMed Web of Science ®Google Scholar
• Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol 1973;28(1):1-9
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011;10(10):922-30
   PubMed Web of Science ®Google Scholar
• Capovilla G, Beccaria F, Beghi E, et al. Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy. Epilepsia 2013;54(Suppl 7):23-34
   PubMed Web of Science ®Google Scholar
• Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17(3):348-55
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Alvarez V, Januel JM, Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013;260(2):421-8
   PubMed Web of Science ®Google Scholar
• Jaques L, Rossetti AO. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis. Epilepsy Behav 2012;24(1):70-3
   PubMed Web of Science ®Google Scholar
• Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014;82(8):656-64
   PubMed Web of Science ®Google Scholar
• Marchi NA, Novy J, Faouzi M, et al. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med 2015;43(5):1003-9
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Bleck TP. What’s new in status epilepticus? Intensive Care Med 2014;40(9):1359-62
   PubMed Web of Science ®Google Scholar
• Synowiec AS, Singh DS, Yenugadhati V, et al. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013;105(1-2):183-8
   PubMed Web of Science ®Google Scholar
• Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia 2013;54(8):1498-503
   PubMed Web of Science ®Google Scholar
• Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008;82(2-3):219-22
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999;265(3):187-90
   PubMed Web of Science ®Google Scholar
• Caraballo RH, Flesler S, Armeno M, et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res 2014;108(10):1912-16
   PubMed Web of Science ®Google Scholar
• Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82(8):665-70
   PubMed Web of Science ®Google Scholar
• Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol 2011;24(2):146-53
   PubMed Web of Science ®Google Scholar
• Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12(2):157-65
   PubMed Web of Science ®Google Scholar
• Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 2009;86(2-3):101-12
   PubMed Web of Science ®Google Scholar
• Miskin C, Hasbani DM. Status epilepticus: immunologic and inflammatory mechanisms. Semin Pediatr Neurol 2014;21(3):221-5
   PubMed Web of Science ®Google Scholar
• Vezzani A, Balosso S, Aronica E, Ravizza T. Basic mechanisms of status epilepticus due to infection and inflammation. Epilepsia 2009;50(Suppl 12):56-7
   PubMedGoogle Scholar
• Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7(1):31-40
   PubMed Web of Science ®Google Scholar
• Lewis DV, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol 2014;75(2):178-85
   PubMed Web of Science ®Google Scholar
• Nixon J, Bateman D, Moss T. An MRI and neuropathological study of a case of fatal status epilepticus. Seizure 2001;10(8):588-91
   PubMed Web of Science ®Google Scholar
• Corsellis JA, Bruton CJ. Neuropathology of status epilepticus in humans. Adv Neurol 1983;34:129-39
   PubMedGoogle Scholar
• Fujikawa DG, Itabashi HH, Wu A, Shinmei SS. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000;41(8):981-91
   PubMed Web of Science ®Google Scholar
• Choi J, Nordli DRJr, Alden TD, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009;6:38
   PubMed Web of Science ®Google Scholar
• Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune response in epilepsy. Glia 2012;60(8):1258-68
   PubMed Web of Science ®Google Scholar
• Ravizza T, Gagliardi B, Noé F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29(1):142-60
   PubMed Web of Science ®Google Scholar
• Zattoni M, Mura ML, Deprez F, et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 2011;31(11):4037-50
   PubMed Web of Science ®Google Scholar
• Iori V, Maroso M, Rizzi M, et al. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 2013;58:102-14
   PubMed Web of Science ®Google Scholar
• Ashhab MU, Omran A, Kong H, et al. Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy. J Mol Neurosci 2013;51(3):950-8
   PubMed Web of Science ®Google Scholar
• Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010;16(4):413-19
   PubMed Web of Science ®Google Scholar
• Aronica E, Crino PB. Inflammation in epilepsy: clinical observations. Epilepsia 2011;52(Suppl 3):26-32
   PubMed Web of Science ®Google Scholar
• Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135(Pt 5):1622-38
   PubMed Web of Science ®Google Scholar
• Pardo CA, Vining EP, Guo L, et al. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004;45(5):516-26
   PubMed Web of Science ®Google Scholar
• Liu ZS, Wang QW, Wang FL, Yang LZ. Serum cytokine levels are altered in patients with West syndrome. Brain Dev 2001;23(7):548-51
   PubMed Web of Science ®Google Scholar
• Liimatainen S, Lehtimaki K, Palmio J, et al. Immunological perspectives of temporal lobe seizures. J Neuroimmunol 2013;263(1-2):1-7
   PubMed Web of Science ®Google Scholar
• Choi J, Min HJ, Shin JS. Increased levels of HMGB1 and pro-inflammatory cytokines in children with febrile seizures. J Neuroinflammation 2011;8:135
   PubMed Web of Science ®Google Scholar
• van Vliet EA, da Costa Araujo S, Redeker S, et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007;130(2):521-34
   PubMedGoogle Scholar
• Juhasz C, Buth A, Chugani DC, et al. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus 2013;34(6):E5
   PubMedGoogle Scholar
• Sakuma H, Tanuma N, Kuki I, et al. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry 2014;86(7):820-2
   PubMed Web of Science ®Google Scholar
• Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013;69:16-24
   PubMed Web of Science ®Google Scholar
• Jiang J, Dingledine R. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection. Trends Pharmacol Sci 2013;34(7):413-23
   PubMed Web of Science ®Google Scholar
• van Vliet EA, Aronica E, Gorter JA. Blood-brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol 2015;38:26-34
   PubMed Web of Science ®Google Scholar
• Vezzani A, Maroso M, Balosso S, et al. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011;25(7):1281-9
   PubMed Web of Science ®Google Scholar
• Rojas A, Jiang J, Ganesh T, et al. Cyclooxygenase-2 in epilepsy. Epilepsia 2014;55(1):17-25
   PubMed Web of Science ®Google Scholar
• De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12(7):2623-33
   PubMed Web of Science ®Google Scholar
• Dhote F, Peinnequin A, Carpentier P, et al. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007;238(2-3):166-76
   PubMed Web of Science ®Google Scholar
• Williams AJ, Berti R, Yao C, et al. Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci Lett 2003;349(3):147-50
   PubMed Web of Science ®Google Scholar
• Pernot F, Heinrich C, Barbier L, et al. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 2011;52(12):2315-25
   PubMed Web of Science ®Google Scholar
• Rojas A, Ganesh T, Lelutiu N, et al. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus. Neuropharmacology 2015;93:15-27
   PubMed Web of Science ®Google Scholar
• Jiang J, Yang MS, Quan Y, et al. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus. Neurobiol Dis 2015;76:126-36
   PubMed Web of Science ®Google Scholar
• Jiang J, Quan Y, Ganesh T, et al. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proc Natl Acad Sci USA 2013;110(9):3591-6
   PubMed Web of Science ®Google Scholar
• Borges K, Gearing M, McDermott DL, et al. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 2003;182(1):21-34
   PubMed Web of Science ®Google Scholar
• Serrano GE, Lelutiu N, Rojas A, et al. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J Neurosci 2011;31(42):14850-60
   PubMed Web of Science ®Google Scholar
• Librizzi L, Noé F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 2012;72(1):82-90
   PubMed Web of Science ®Google Scholar
• Noé FM, Polascheck N, Frigerio F, et al. Pharmacological blockade of IL-1beta/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 2013;59:183-93
   PubMed Web of Science ®Google Scholar
• Marchi N, Fan Q, Ghosh C, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009;33(2):171-81
   PubMed Web of Science ®Google Scholar
• Bellavance MA, Gosselin D, Yong VW, et al. Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity. Brain Struct Funct 2015;220(3):1759-76
   PubMed Web of Science ®Google Scholar
• Rizzi M, Perego C, Aliprandi M, et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003;14(3):494-503
   PubMed Web of Science ®Google Scholar
• Marcon J, Gagliardi B, Balosso S, et al. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis 2009;34(1):121-32
   PubMed Web of Science ®Google Scholar
• Dubé C, Vezzani A, Behrens M, et al. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 2005;57(1):152-5
   PubMed Web of Science ®Google Scholar
• Ravizza T, Rizzi M, Perego C, et al. Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 2005;46(Suppl 5):113-17
   PubMedGoogle Scholar
• Haut SR, Veliskova J, Moshé SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 2004;3(10):608-17
   PubMed Web of Science ®Google Scholar
• Dubé CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010;30(22):7484-94
   PubMed Web of Science ®Google Scholar
• Choy M, Dubé CM, Patterson K, et al. A novel, noninvasive, predictive epilepsy biomarker with clinical potential. J Neurosci 2014;34(26):8672-84
   PubMed Web of Science ®Google Scholar
• Galic MA, Riazi K, Heida JG, et al. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008;28(27):6904-13
   PubMed Web of Science ®Google Scholar
• Galic MA, Riazi K, Henderson AK, et al. Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 2009;36(2):343-51
   PubMed Web of Science ®Google Scholar
• Colciaghi F, Finardi A, Frasca A, et al. Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia. Brain 2011;134(Pt 10):2828-43
   PubMedGoogle Scholar
• Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999;19(12):5054-65
   PubMed Web of Science ®Google Scholar
• Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26(3):497-511
   PubMed Web of Science ®Google Scholar
• Pernhorst K, Herms S, Hoffmann P, et al. TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure 2013;22(8):675-8
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration. Cell 2010;140(6):918-34
   PubMed Web of Science ®Google Scholar
• Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005;18(3):315-21
   PubMed Web of Science ®Google Scholar
• Craft JM, Watterson DM, Van Eldik LJ. Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targets 2005;9(5):887-900
   PubMed Web of Science ®Google Scholar
• Xiong ZQ, Qian W, Suzuki K, McNamara JO. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 2003;23(3):955-60
   PubMed Web of Science ®Google Scholar
• Ravizza T, Balosso S, Aronica E, Vezzani A. Brain inflammation and epilepsy. In: Rho JM, Sankar R, Strafstrom CE, editors. Epilepsy: mechanisms, models and translational perspectives. CRC Press, Boca Raton, FL, USA; 2010
   Google Scholar
• Kulkarni SK, Dhir A. Cyclooxygenase in epilepsy: from perception to application. Drugs Today (Barc) 2009;45(2):135-54
   PubMed Web of Science ®Google Scholar
• Benson MJ, Thomas NK, Talwar S, et al. A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models. Neurobiol Dis 2015;76:87-97
   PubMed Web of Science ®Google Scholar
• Henshall DC, Engel T. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus. Epilepsy Behav 2015; Epub ahead of print
   Web of Science ®Google Scholar
• Henshall DC, Diaz-Hernandez M, Miras-Portugal MT, Engel T. P2X receptors as targets for the treatment of status epilepticus. Front Cell Neurosci 2013;7:237
   PubMedGoogle Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell 2010;140(6):821-32
   PubMed Web of Science ®Google Scholar
• Lu B, Wang H, Andersson U, Tracey KJ. Regulation of HMGB1 release by inflammasomes. Protein Cell 2013;4(3):163-7
   PubMed Web of Science ®Google Scholar
• Marchi N, Granata T, Freri E, et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 2011;6(3):e18200
   PubMed Web of Science ®Google Scholar
• Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009;64(1):33-9
   PubMed Web of Science ®Google Scholar
• Duffy BA, Chun KP, Ma D, et al. Dexamethasone exacerbates cerebral edema and brain injury following lithium-pilocarpine induced status epilepticus. Neurobiol Dis 2014;63:229-36
   PubMed Web of Science ®Google Scholar
• Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacol 2015;96(Pt A):70-82
   PubMedGoogle Scholar
• Fourgeaud L, Boulanger LM. Role of immune molecules in the establishment and plasticity of glutamatergic synapses. Eur J Neurosci 2010;32(2):207-17
   PubMed Web of Science ®Google Scholar
• Carpentier PA, Palmer TD. Immune influence on adult neural stem cell regulation and function. Neuron 2009;64(1):79-92
   PubMed Web of Science ®Google Scholar
• Galanopoulou AS, Moshé SL. The epileptic hypothesis: developmentally related arguments based on animal models. Epilepsia 2009;50(Suppl 7):37-42
   PubMedGoogle Scholar
• Heida JG, Pittman QJ. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia 2005;46(12):1906-13
   PubMed Web of Science ®Google Scholar
• Heida JG, Moshé SL, Pittman QJ. The role of interleukin-1beta in febrile seizures. Brain Dev 2009;31(5):388-93
   PubMed Web of Science ®Google Scholar
• Dubé C, Richichi C, Bender RA, et al. Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 2006;129(Pt 4):911-22
   PubMedGoogle Scholar
• Sankar R, Auvin S, Mazarati A, Shin D. Inflammation contributes to seizure-induced hippocampal injury in the neonatal rat brain. Acta Neurol Scand 2007;115(4):16-20
   PubMedGoogle Scholar
• Somera-Molina KC, Robin B, Somera CA, et al. Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 2007;48(9):1785-800
   PubMed Web of Science ®Google Scholar
• Auvin S, Mazarati A, Shin D. Inflammation enhances epileptogenesis in immature rat brain. Neurobiol Dis 2010;40(1):303-10
   PubMed Web of Science ®Google Scholar
• Reid AY, Riazi K, Campbell Teskey G, Pittman QJ. Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia 2013;54(4):e45-8
   PubMed Web of Science ®Google Scholar
• Harré EM, Galic MA, Mouihate A, et al. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 2008;27(3):644-53
   PubMed Web of Science ®Google Scholar
• Garcia-Morales I, de la Pena Mayor P, Kanner AM. Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist 2008;14(6 Suppl 1):S15-25
   PubMed Web of Science ®Google Scholar
• Tarr AJ, McLinden KA, Kranjac D, et al. The effects of age on lipopolysaccharide-induced cognitive deficits and interleukin-1beta expression. Behav Brain Res 2011;217(2):481-5
   PubMed Web of Science ®Google Scholar
• Goshen I, Yirmiya R. Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009;30(1):30-45
   PubMed Web of Science ®Google Scholar
• Mazarati A, Maroso M, Iori V, et al. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products. Exp Neurol 2011;232(2):143-8
   PubMed Web of Science ®Google Scholar
• Smith SE, Li J, Garbett K, et al. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007;27(40):10695-702
   PubMed Web of Science ®Google Scholar
• Emanuele E, Boso M, Brondino N, et al. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(4):681-3
   PubMed Web of Science ®Google Scholar
• Boso M, Emanuele E, Minoretti P, et al. Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci Lett 2006;410(3):169-73
   PubMed Web of Science ®Google Scholar
• Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 2010;24(1):64-71
   PubMed Web of Science ®Google Scholar
• Sun J, Xie C, Liu W, et al. The effects of simvastatin on hippocampal caspase-3 and Bcl-2 expression following kainate-induced seizures in rats. Int J Mol Med 2012;30(4):739-46
   PubMed Web of Science ®Google Scholar
• van Vliet EA, Holtman L, Aronica E, et al. Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy. Epilepsia 2011;52(7):1319-30
   PubMed Web of Science ®Google Scholar
• Xie C, Sun J, Qiao W, et al. Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy. PLoS One 2011;6(9):e24966
   PubMed Web of Science ®Google Scholar
• Sierra-Marcos A, Alvarez V, Faouzi M, et al. Statins are associated with decreased mortality risk after status epilepticus. Eur J Neurol 2015;22(2):402-5
   PubMed Web of Science ®Google Scholar
• Vezzani A. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis? Expert Opin Drug Saf 2015;14(4):583-92
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Lee ST, et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 2006;23(2):237-46
   PubMed Web of Science ®Google Scholar
• Polascheck N, Bankstahl M, Loscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 2010;224(1):219-33
   PubMed Web of Science ®Google Scholar
• Ma L, Cui XL, Wang Y, et al. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats. Brain Res 2012;1469:103-13
   PubMed Web of Science ®Google Scholar
• Fabene PF, Mora GN, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14(12):1377-83
   PubMed Web of Science ®Google Scholar
• Chu K, Jung KH, Lee ST, et al. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008;49(10):1723-32
   PubMed Web of Science ®Google Scholar
• Gao F, Liu Y, Li X, et al. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model. Pharmacol Biochem Behav 2012;103(2):187-96
   PubMed Web of Science ®Google Scholar
• Wang N, Mi X, Gao B, et al. Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neuroscience 2015;287:144-56
   PubMed Web of Science ®Google Scholar
• Kwon YS, Pineda E, Auvin S, et al. Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J Neuroinflammation 2013;10:30
   PubMed Web of Science ®Google Scholar
• Mazzuferi M, Kumar G, van Eyll J, et al. Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy. Ann Neurol 2013;74(4):560-8
   PubMed Web of Science ®Google Scholar
• Gouveia TL, Scorza FA, Iha HA, et al. Lovastatin decreases the synthesis of inflammatory mediators during epileptogenesis in the hippocampus of rats submitted to pilocarpine-induced epilepsy. Epilepsy Behav 2014;36:68-73
   PubMed Web of Science ®Google Scholar